Deferasirox NOBEL 360 mg Compresse rivestite con film সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

deferasirox nobel 360 mg compresse rivestite con film

nobel pharma schweiz ag - deferasiroxum - compresse rivestite con film - deferasiroxum 360 mg, cellulosum microcristallinum, crospovidonum, povidonum k 30, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Überzug: crospovidonum, poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 132, e 172 (flavum), pro compresso obducto. - eisenchelator - synthetika

Nityr 2 mg Compresse সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nityr 2 mg compresse

curatis ag - nitisinonum - compresse - nitisinonum 2 mg, glyceroli dibehenas, lactosum monohydricum 116.4 mg, pro compresso. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Nityr 5 mg Compresse সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nityr 5 mg compresse

curatis ag - nitisinonum - compresse - nitisinonum 5 mg, glyceroli dibehenas, lactosum monohydricum 113.4 mg, pro compresso. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Nityr 10 mg Compresse সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nityr 10 mg compresse

curatis ag - nitisinonum - compresse - nitisinonum 10 mg, glyceroli dibehenas, lactosum monohydricum 108.4 mg, pro compresso. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Nitisinon NOBEL 5 mg Capsule rigide সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nitisinon nobel 5 mg capsule rigide

nobel pharma schweiz ag - nitisinonum - capsule rigide - nitisinonum 5.00 mg, amylum pregelificatum, e 133, e 127, e 171, e 110 0.008 mg, gelatina, pro capsula. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Nitisinon NOBEL 10 mg Capsule rigide সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nitisinon nobel 10 mg capsule rigide

nobel pharma schweiz ag - nitisinonum - capsule rigide - nitisinonum 10.00 mg, amylum pregelificatum, e 171, e 132, aqua, gelatina, pro capsula. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Nitisinon NOBEL 20 mg Capsule rigide সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nitisinon nobel 20 mg capsule rigide

nobel pharma schweiz ag - nitisinonum - capsule rigide - nitisinonum 20.00 mg, amylum pregelificatum, e 171, gelatina, pro capsula. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Nitisinon NOBEL 4 mg/ml Sospensione সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

nitisinon nobel 4 mg/ml sospensione

nobel pharma schweiz ag - nitisinonum - sospensione - nitisinonum 4.00 mg, hypromellosum, glycerolum 500 mg, polysorbatum 80, e 211 1.00 mg, acidum tartaricum, aromatica (erdbeeren) cum propylenglycolum, aqua purificata ad solutionem pro 1 ml corresp. natrium 0.1595 mg. - hereditäre tyrosinämie typ 1 (ht-1) - synthetika

Ximluci ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologici - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Tecvayli 30 mg/3 ml Soluzione iniettabile সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

tecvayli 30 mg/3 ml soluzione iniettabile

janssen-cilag ag - teclistamabum - soluzione iniettabile - teclistamabum 30 mg, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 0.75 mg. - multipli myelom - biotechnologika